Cargando…
Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
Statins have a primary indication for the reduction and management of hypercholesterolemia; however, evidence shows that statins have the ability to increase the toxicity of chemotherapeutics within cancer cells by inducing anti-proliferative, anti-metastatic, and anti-angiogenic effects. More recen...
Autores principales: | Anderson, Colin C., Khatri, Meera, Roede, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184108/ https://www.ncbi.nlm.nih.gov/pubmed/32368502 http://dx.doi.org/10.1016/j.toxrep.2020.03.007 |
Ejemplares similares
-
Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells
por: Kuzyk, Crystal L., et al.
Publicado: (2020) -
Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin
por: Platel, D, et al.
Publicado: (1999) -
Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields
por: Sauer, H, et al.
Publicado: (1999) -
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice
por: Balsari, A, et al.
Publicado: (2001) -
Simvastatin augmentation for recent-onset psychotic disorder: A study protocol
por: Begemann, Marieke J.H., et al.
Publicado: (2015)